🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How can we change the narrative in obesity treatment and care? Read this article to find out how the imisophia project views #obesity as a set of different diseases as it aims to create more personalized treatment: tandfonline.com/doi/full/10.10…

🔬🚨 We published a new study JHEP Reports: "A missense variant in PLIN2 Ser251Pro Reduces Hepatic Steatosis in Mice" jhep-reports.eu/article/S2589-… Carolin V. Schneider, MD @RotonyaC @ktc_phd Sookyoung Jeon Delfin Gerard Buyco Marijana Vujković Nick Hand, PhD Clementina Mesaros Marie Guerraty MD, PhD Yedidya Saiman

join us today and tomorrow for the NAFLD study group annual webinar, from 4pm CET with Catherine Postic, Bart Staels, Hannele Yki Jarvinen, Stefano Romeo, Chris Byrne. Today presentations from Dr. Fawaz Alzaid, Joel Haas, Caitlin Myers. Program and registration nafldgroup.eu

You still have time to submit an #abstract for the EGIR annual meeting "#hyperinsulinemia in metabolic diseases: impact of #secretion, #clearance and homeostasis"! Deadline on Wednesday, November 8th, 12CET! +info egir-group.eu EASDelearning EASD #insulin #wdd2023

Do not miss the EGIR Annual Webinar! Check the program below and register at us02web.zoom.us/webinar/regist… EASDelearning #insulin #clearance #metabolism #homeostasis

Congratulations Jeffrey V. Lazarus, well deserved.

proud of this recognition Clarivate CNR Consiglio Nazionale delle Ricerche we need more women in science #STEMweek

I enjoyed the Keystone Symposia in Vancouver talking about different mechanisms of #obesity from #genetics to #brain and #adipose_tissue dysfunction. Thanks Karine Clement and Giles Yeo for the invitation

Diabetes Care, a research journal of the ADA 🌟 is calling on artists: Share your creativity with the world and submit original artwork for the journal cover! 🎨✨ Find out more and showcase your talent at diabetesjournals.org/care/pages/sub…! 🖌️📖 #DiabetesCare #ArtSubmission ADA Professional Publications #WelchWOW

Elia Casirati presenting the modeling the impact of the PNPLA3 variant on #MASLD steatotic liver disease in human #liver #organoids #keystone meeting Banff ⁦Stefano Romeo⁩ ⁦Yaron Rotman⁩ ⁦Amalia Gastaldelli⁩ ⁦Alina Allen⁩ ⁦⁦⁦Silvia Sookoian⁩

Thanks ⁦Stefano Romeo⁩ and ⁦Silvia Sookoian⁩ for great time and science #keystone. Here with ⁦Luca Valenti⁩, Luca Lotta, Julia Kozlitina, ⁦Elia Casirati⁩ and Celine Hoffmann

Last day #keystone on MASH. Thanks ⁦Stefano Romeo⁩, ⁦Silvia Sookoian⁩, ⁦Michael Charlton MD, FRCP⁩ and Gregory Tesz for the excellent program

Another picture from #keystone on MASH, ⁦here with ⁩Maru Rinella MD⁩, Michael Charlton MD, FRCP, ⁦Luca Valenti⁩ and the young ⁦Elia Casirati⁩.

Great discussions on #AI_in_Health during the World Health Forum organized by Gaudenzio Meneghesso,, Roberto Vettor of Università di Padova. Great opportunity to be back in Padova, see old friends and new people, like Giuseppe Lauria, Henning Müller, Matej Oresic, Giovanni Sparacino.

Congratulations Silvia for these results on variable response to lifestyle! And thanks to Donal O'Gorman and John Nolan, Dexlife DCU EGIR Study Group imisophia

This Wednesday 18:00 CEST, join faculty Aleksander Krag, Naim Alkhouri, Sven Francque & Amalia Gastaldelli for a fascinating discussion on Resmetirom, the 1st approved drug for #MASH. 📺 easl.eu/easl-studio-ep… #LiverTwitter

🙏 EASLnews Global Liver Institute for hosting a great meeting at #WHA77 👉 SLD is an NCD! 💪 joining forces with EASD World Obesity ECPO EASO #ESOT 👉 multistakeholder collaboration is key 💪European Liver Patients' Association #AntwerpHepatology

At-risk populations: Screening should focus on individuals with abdominal obesity, type 2 diabetes, prediabetes, or other cardiometabolic risk factors, as these are strongly linked to SLD and fibrosis progression. With rising rates of diabetes and obesity, SLD prevalence is

🍭 #MASLD is now the most common chronic liver disease globally — affecting over a third of adults. Closely tied to obesity, type 2 diabetes, and poor nutrition, MASLD is a silent epidemic with serious risks: cirrhosis, liver cancer, and cardiovascular disease. The 2024

It was a privilege to chair this session with Sven Francque at #EASLCongress yesterday